KESHAV
USD 233.33
1,900+ مباعصيدلية فعلية في هونغ كونغ مع ضمان اصالة 100%
Anamorelin, a prescription medicine targeting the ghrelin receptor GHS-R1a, was approved in Japan in January 2021 and launched in April of the same year. Use it only as directed by a physician.
10000 متوفر في المخزون
Indicated for adults with cancer cachexia associated with malignant tumors such as non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer.
Anamorelin آلية العمل آلية العمل ，
Please use this product according to the package instructions, pharmacist review, or your doctor’s advice. Do not adjust the dose on your own.
EMA Refused - No
Indicated for adults with cancer cachexia associated with malignant tumors such as non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer.
Please use this product according to the package instructions, pharmacist review, or your doctor’s advice. Do not adjust the dose on your own.
EMA Refused - No
دواعي الاستعمال
Indicated for adults with cancer cachexia associated with malignant tumors such as non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer.
الية العمل
Anamorelin آلية العمل آلية العمل ，
الجرعة
Please use this product according to the package instructions, pharmacist review, or your doctor’s advice. Do not adjust the dose on your own.
الاحتياطات
EMA Refused - No
